These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16230891)

  • 1. Tecadenoson: a novel, selective A1 adenosine receptor agonist.
    Peterman C; Sanoski CA
    Cardiol Rev; 2005; 13(6):315-21. PubMed ID: 16230891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.
    Prystowsky EN; Niazi I; Curtis AB; Wilber DJ; Bahnson T; Ellenbogen K; Dhala A; Bloomfield DM; Gold M; Kadish A; Fogel RI; Gonzalez MD; Belardinelli L; Shreeniwas R; Wolff AA
    J Am Coll Cardiol; 2003 Sep; 42(6):1098-102. PubMed ID: 13678937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.
    Ellenbogen KA; O'Neill G; Prystowsky EN; Camm JA; Meng L; Lieu HD; Jerling M; Shreeniwas R; Belardinelli L; Wolff AA;
    Circulation; 2005 Jun; 111(24):3202-8. PubMed ID: 15956124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CVT-510: a selective A1 adenosine receptor agonist.
    Cheung JW; Lerman BB
    Cardiovasc Drug Rev; 2003; 21(4):277-92. PubMed ID: 14647532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.
    Lepist EI; Damaraju VL; Zhang J; Gati WP; Yao SY; Smith KM; Karpinski E; Young JD; Leung KH; Cass CE
    Drug Metab Dispos; 2013 Apr; 41(4):916-22. PubMed ID: 23388705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Janus face of adenosine: antiarrhythmic and proarrhythmic actions.
    Szentmiklosi AJ; Galajda Z; Cseppento Á; Gesztelyi R; Susán Z; Hegyi B; Nánási PP
    Curr Pharm Des; 2015; 21(8):965-76. PubMed ID: 25354187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial Adenosine A1 Agonist in Heart Failure.
    Dinh W; Albrecht-Küpper B; Gheorghiade M; Voors AA; van der Laan M; Sabbah HN
    Handb Exp Pharmacol; 2017; 243():177-203. PubMed ID: 27770217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CVT-510 (CV Therapeutics).
    Zaza A
    Curr Opin Investig Drugs; 2002 Jan; 3(1):96-100. PubMed ID: 12054080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine in the episodic treatment of paroxysmal supraventricular tachycardia.
    Parker RB; McCollam PL
    Clin Pharm; 1990 Apr; 9(4):261-71. PubMed ID: 2184971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.
    Corino VD; Holmqvist F; Mainardi LT; Platonov PG
    Europace; 2014 Apr; 16(4):587-94. PubMed ID: 23989533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INO-8875, a highly selective A1 adenosine receptor agonist: evaluation of chronotropic, dromotropic, and hemodynamic effects in rats.
    Mor M; Shalev A; Dror S; Pikovsky O; Beharier O; Moran A; Katz A; Etzion Y
    J Pharmacol Exp Ther; 2013 Jan; 344(1):59-67. PubMed ID: 23055540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine: novel antiarrhythmic therapy for supraventricular tachycardia.
    Nagelhout JJ
    AANA J; 1992 Jun; 60(3):287-92. PubMed ID: 1632157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia.
    Gausche M; Persse DE; Sugarman T; Shea SR; Palmer GL; Lewis RJ; Brueske PJ; Mahadevan S; Melio FR; Kuwate JH
    Ann Emerg Med; 1994 Aug; 24(2):183-9. PubMed ID: 8037382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation.
    Corino VD; Sandberg F; Mainardi LT; Platonov PG; Sörnmo L
    Ann Noninvasive Electrocardiol; 2015 Nov; 20(6):534-41. PubMed ID: 25545540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
    Ballo P; Bernabò D; Faraguti SA
    Eur Heart J; 2004 Aug; 25(15):1310-7. PubMed ID: 15288158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenosine, its analogues and conjugates].
    Samsel M; Dzierzbicka K; Trzonkowski P
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1189-203. PubMed ID: 24379260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paroxysmal supraventricular tachycardia in pregnancy. Value of adenosine and other anti-arrhythmia agents].
    Hösl P; Rust M; Johannigmann J; Schmidt G
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):313-6. PubMed ID: 8766489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of paroxysmal supraventricular tachycardia with adenosine: implications for nursing.
    Severson AL; Meyer LT
    Heart Lung; 1992; 21(4):350-6. PubMed ID: 1629004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine as a therapeutic agent.
    Mosqueda-Garcia R
    Clin Invest Med; 1992 Oct; 15(5):445-55. PubMed ID: 1458718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful conversion of unstable supraventricular tachycardia to sinus rhythm with adenosine.
    Melio FR; Mallon WK; Newton E
    Ann Emerg Med; 1993 Apr; 22(4):709-13. PubMed ID: 8457100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.